Constantine Chinoporos - Dec 28, 2023 Form 4 Insider Report for Applied Therapeutics, Inc. (APLT)

Role
Chief Operating Officer and Chief Business Officer
Signature
/s/ Shoshana Shendelman, as attorney-in-fact
Stock symbol
APLT
Transactions as of
Dec 28, 2023
Transactions value $
$0
Form type
4
Date filed
3/18/2024, 05:51 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLT Common Stock Award $0 +300K $0.00 300K Dec 28, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan (the "Plan"). Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on December 28, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.

Remarks:

Chief Operating Officer and Chief Business Officer